Total Payments
$46,700
2024 Payments
$11,946
Companies
21
Transactions
198
Medicare Patients
487
Medicare Billing
$75,374
Payment Breakdown by Category
Consulting$35,365 (75.7%)
Food & Beverage$8,373 (17.9%)
Travel$2,502 (5.4%)
Education$461.09 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,365 | 12 | 75.7% |
| Food and Beverage | $8,373 | 171 | 17.9% |
| Travel and Lodging | $2,502 | 7 | 5.4% |
| Education | $461.09 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $22,661 | 65 | $0 (2024) |
| Genentech USA, Inc. | $10,681 | 12 | $0 (2024) |
| Biogen, Inc. | $9,719 | 28 | $0 (2024) |
| TG Therapeutics, Inc. | $1,034 | 20 | $0 (2024) |
| Celgene Corporation | $480.26 | 18 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $367.53 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $321.86 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $278.04 | 5 | $0 (2022) |
| Amgen Inc. | $148.17 | 7 | $0 (2024) |
| ABBVIE INC. | $144.04 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,946 | 79 | EMD Serono, Inc. ($9,601) |
| 2023 | $10,907 | 53 | EMD Serono, Inc. ($10,097) |
| 2022 | $9,589 | 37 | Genentech USA, Inc. ($8,028) |
| 2021 | $5,085 | 15 | Genentech USA, Inc. ($2,400) |
| 2020 | $155.56 | 3 | Biogen, Inc. ($144.35) |
| 2019 | $9,017 | 11 | Biogen, Inc. ($8,892) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Neurology | ||||||
| 12/16/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| Category: Neurology | ||||||
| 12/16/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.36 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 11/21/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.93 | General |
| 11/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $138.49 | General |
| 11/16/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $300.31 | General |
| 11/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $86.89 | General |
| 11/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $84.65 | General |
| 11/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $74.99 | General |
| 11/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.83 | General |
| 11/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Immunology | ||||||
| 10/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $95.00 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $141.21 | General |
| 09/27/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/20/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 168 | 264 | $67,091 | $23,300 |
| 2022 | 3 | 151 | 308 | $75,380 | $26,002 |
| 2021 | 3 | 120 | 251 | $60,195 | $21,755 |
| 2020 | 1 | 48 | 60 | $14,700 | $4,317 |
Total Patients
487
Total Services
883
Medicare Billing
$75,374
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 96 | 185 | $46,196 | $15,568 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $8,720 | $3,105 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 30 | $4,800 | $2,168 | 45.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,500 | $1,555 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $2,875 | $904.65 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 88 | 236 | $58,260 | $19,219 | 33.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 40 | $12,000 | $4,934 | 41.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 32 | $5,120 | $1,850 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 211 | $51,695 | $18,132 | 35.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $4,500 | $1,934 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 25 | $4,000 | $1,690 | 42.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 48 | 60 | $14,700 | $4,317 | 29.4% |
About Christopher Langston
Christopher Langston is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1902295165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Langston has received a total of $46,700 in payments from pharmaceutical and medical device companies, with $11,946 received in 2024. These payments were reported across 198 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($35,365).
As a Medicare-enrolled provider, Langston has provided services to 487 Medicare beneficiaries, totaling 883 services with total Medicare billing of $75,374. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Bronx, NY
- Active Since 01/12/2015
- Last Updated 09/24/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902295165
Products in Payments
- OCREVUS (Biological) $10,428
- Mavenclad (Drug) $10,096
- MAVENCLAD (Drug) $9,123
- BRIUMVI (Drug) $1,034
- ZEPOSIA (Drug) $758.30
- VUMERITY (Drug) $474.45
- KESIMPTA (Drug) $310.65
- TYSABRI (Biological) $294.41
- ULTOMIRIS (Biological) $242.53
- Ocrevus (Biological) $170.44
- UPLIZNA (Biological) $148.17
- UBRELVY (Drug) $144.04
- DISEASE STATE (Drug) $125.00
- XCOPRI (Drug) $124.99
- SHINGRIX (Biological) $121.84
- Vumerity (Drug) $107.73
- Ponvory (Drug) $95.99
- KISUNLA (Drug) $95.00
- PURIFIED CORTROPHIN GEL (Drug) $66.70
- UPLIZNA (Drug) $42.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bronx
Richard Lipton, Md, MD
Neurology — Payments: $982,914
Neurology $982,914
Michael Thorpy, Md, MD
Neurology — Payments: $451,587
Neurology $451,587
Rene Elkin, Md, MD
Neurology — Payments: $343,327
Neurology $343,327
Jelena Pavlovic, M.d, M.D
Neurology — Payments: $130,235
Neurology $130,235
Dr. Sandeep Gulati, D.o, D.O
Neurology — Payments: $124,853
Neurology $124,853
Dr. Lauren Gluck, Md, MD
Neurology — Payments: $53,848
Neurology $53,848